Non-invasive screening for colorectal cancer in Asia

Best Practice and Research: Clinical Gastroenterology

Volumn 29, Issue 6, 2015, Pages 953-965

  Chiu, Han Mo ^a   Chang, Li Chun ^a   Hsu, Wen Feng ^a   Chou, Chu Kuang ^b   Wu, Ming Shiang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Asia; Colorectal cancer (CRC); Fecal immunochemical test (FIT); Guaiac fecal occult blood test (gFOBT); Screening

Indexed keywords

ASIA; AUSTRALIA; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; GUAIAC FECAL OCCULT BLOOD TEST; HIGH RISK POPULATION; HUMAN; JAPAN; KOREA; MASS SCREENING; NON INVASIVE PROCEDURE; REVIEW; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SINGAPORE; TAIWAN; COLORECTAL NEOPLASMS; FECES; INCIDENCE; OCCULT BLOOD; PROCEDURES;

DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; GUAIAC;

ASIA; COLORECTAL NEOPLASMS; FECES; GUAIAC; HUMANS; INCIDENCE; INDICATORS AND REAGENTS; MASS SCREENING; OCCULT BLOOD;

EID: 84945919547     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2015.09.015     Document Type: Review

References (56)

1. J.S.I. Ferlay, M. Ervik, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, and et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet] 2013 International Agency for Research on Cancer Lyon, France 2015
2. J.J. Sung, J.Y. Lau, K.L. Goh, W.K. Leung Asia Pacific Working Group on Colorectal C Increasing incidence of colorectal cancer in Asia: implications for screening Lancet Oncol 6 2005 871 876
3. Taiwan Cancer Registry 2011 Health promotion administration 2015 Ministry of Health and Welfare
4. J.J. Sung, J.Y. Lau, G.P. Young, Y. Sano, H.M. Chiu, J.S. Byeon, and et al. Asia Pacific consensus recommendations for colorectal cancer screening Gut 57 2008 1166 1176
5. J.J. Sung, S.C. Ng, F.K. Chan, H.M. Chiu, H.S. Kim, T. Matsuda, and et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening Gut 64 2015 121 132
6. B. Levin, D.A. Lieberman, B. McFarland, K.S. Andrews, D. Brooks, J. Bond, and et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology 134 2008 1570 1595
7. T.R. Church, M. Wandell, C. Lofton-Day, S.J. Mongin, M. Burger, S.R. Payne, and et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer Gut 63 2014 317 325
8. T.F. Imperiale, D.F. Ransohoff, S.H. Itzkowitz, T.R. Levin, P. Lavin, G.P. Lidgard, and et al. Multitarget stool DNA testing for colorectal-cancer screening N Engl J Med 370 2014 1287 1297
9. S.K. Pedersen, R.T. Baker, A. McEvoy, D.H. Murray, M. Thomas, P.L. Molloy, and et al. A two-gene blood test for methylated DNA sensitive for colorectal cancer PLoS One 10 2015 e0125041
10. V.S. Benson, W.S. Atkin, J. Green, M.R. Nadel, J. Patnick, R.A. Smith, and et al. Toward standardizing and reporting colorectal cancer screening indicators on an international level: the International Colorectal Cancer Screening Network Int J Cancer 130 2012 2961 2973
11. E.H. Schreuders, A. Ruco, L. Rabeneck, R.E. Schoen, J.J. Sung, G.P. Young, and et al. Colorectal cancer screening: a global overview of existing programmes Gut 64 2015 1637 1649
12. E. Quintero, A. Castells, L. Bujanda, J. Cubiella, D. Salas, A. Lanas, and et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening N Engl J Med 366 2012 697 706
13. A.G. Zauber, I. Lansdorp-Vogelaar, A.B. Knudsen, J. Wilschut, M. van Ballegooijen, and K.M. Kuntz Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force Ann Intern Med 149 2008 659 669
14. M.C. Wong, G.K. John, H.W. Hirai, T.Y. Lam, A.K. Luk, J.Y. Ching, and et al. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys Cancer Causes Control 23 2012 1541 1548
15. L. Hol, M.E. van Leerdam, M. van Ballegooijen, A.J. van Vuuren, H. van Dekken, J.C. Reijerink, and et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy Gut 59 2010 62 68
16. J.M. Inadomi, S. Vijan, N.K. Janz, A. Fagerlin, J.P. Thomas, Y.V. Lin, and et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies Arch Intern Med 172 2012 575 582
17. J. Tinmouth, I. Lansdorp-Vogelaar, and J.E. Allison Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know Gut 64 2015 1327 1337
18. D.C. Rockey Occult gastrointestinal bleeding N Engl J Med 341 1999 38 46
19. T.H. Chiang, Y.C. Lee, C.H. Tu, H.M. Chiu, and M.S. Wu Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract CMAJ 183 2011 1474 1481
20. J.S. Mandel, J.H. Bond, T.R. Church, D.C. Snover, G.M. Bradley, L.M. Schuman, and et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study N Engl J Med 328 1993 1365 1371
21. J.D. Hardcastle, J.O. Chamberlain, M.H. Robinson, S.M. Moss, S.S. Amar, T.W. Balfour, and et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer Lancet 348 1996 1472 1477
22. O. Kronborg, C. Fenger, J. Olsen, O.D. Jorgensen, and O. Sondergaard Randomised study of screening for colorectal cancer with faecal-occult-blood test Lancet 348 1996 1467 1471
23. R.F. Logan, J. Patnick, C. Nickerson, L. Coleman, M.D. Rutter, C. von Wagner, and et al. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests Gut 61 2012 1439 1446
24. P. Hewitson, P. Glasziou, E. Watson, B. Towler, and L. Irwig Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update Am J Gastroenterol 103 2008 1541 1549
25. H. Brenner, and S. Tao Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy Eur J Cancer 49 2013 3049 3054
26. D.I. Park, S. Ryu, Y.H. Kim, S.H. Lee, C.K. Lee, C.S. Eun, and et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening Am J Gastroenterol 105 2010 2017 2025
27. L.G. van Rossum, A.F. van Rijn, R.J. Laheij, M.G. van Oijen, P. Fockens, H.H. van Krieken, and et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population Gastroenterology 135 2008 82 90
28. J.K. Lee, E.G. Liles, S. Bent, T.R. Levin, and D.A. Corley Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis Ann Intern Med 160 2014 171 181
29. M. Zorzi, U. Fedeli, E. Schievano, E. Bovo, S. Guzzinati, S. Baracco, and et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test Gut 64 2015 784 790
30. H.M. Chiu, S.L. Chen, A.M. Yen, S.Y. Chiu, J.C. Fann, Y.C. Lee, and et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the one million Taiwanese Screening Program Cancer 121 2015 3221 3229
31. H. Saito Colorectal cancer screening using immunochemical faecal occult blood testing in Japan J Med Screen 13 Suppl. 1 2006 S6 S7
32. Colorectal cancer screening rates in subjects aged 40-69 in 2013 2014 Ministry of Health, Labour and Welfare
33. J.I. Shim, Y. Kim, M.A. Han, H.Y. Lee, K.S. Choi, J.K. Jun, and et al. Results of colorectal cancer screening of the national cancer screening program in Korea, 2008 Cancer Res Treat 42 2010 191 198
34. B.I. Lee, S.P. Hong, S.E. Kim, S.H. Kim, H.S. Kim, S.N. Hong, and et al. Korean guidelines for colorectal cancer screening and polyp detection Clin Endosc 45 2012 25 43
35. National Bowel Cancer Screening Program. Department of Health, Australian Government.
36. T. Khuhaprema, S. Sangrajrang, S. Lalitwongsa, V. Chokvanitphong, T. Raunroadroong, T. Ratanachu-Ek, and et al. Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme BMJ Open 4 2014 e003671
37. K.J. Lee, M. Inoue, T. Otani, M. Iwasaki, S. Sasazuki, S. Tsugane, and et al. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan Cancer Detect Prev 31 2007 3 11
38. Y. Nishino Legislation of cancer registries in Japan- an outline of the national cancer registry Gan To Kagaku Ryoho 42 2015 389 393
39. M. Heijnen, and I. Lansdorp-Vogelaa CRC screening in the Netherlands; issues to consider 2014 National Institute for Public Health and the Environment, Ministry of Helath, Walfare and Sport
40. J.J. Sung, S.Y. Choi, F.K. Chan, J.Y. Ching, J.T. Lau, and S. Griffiths Obstacles to colorectal cancer screening in Chinese: a study based on the health belief model Am J Gastroenterol 103 2008 974 981
41. J.H. Koo, R.W. Leong, J. Ching, K.G. Yeoh, D.C. Wu, A. Murdani, and et al. Knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter study Gastrointest Endosc 76 2012 126 135
42. A.H. van Roon, J.A. Wilschut, L. Hol, M. van Ballegooijen, J.C. Reijerink, H. t Mannetje, and et al. Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance Clin Gastroenterol Hepatol 9 2011 333 339
43. T.H. Chiang, S.L. Chuang, S.L. Chen, H.M. Chiu, A.M. Yen, S.Y. Chiu, and et al. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program Gastroenterology 147 2014 1317 1326
44. L.S. Chen, C.S. Liao, S.H. Chang, H.C. Lai, and T.H. Chen Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16) J Med Screen 14 2007 191 199
45. K.E. Nnoaham, and C. Lines Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme Gut 57 2008 1238 1245
46. S.N. Hong, D.H. Yang, Y.H. Kim, S.P. Hong, S.J. Shin, S.E. Kim, and et al. Korean guidelines for post-polypectomy colonoscopic surveillance Korean J Gastroenterol 59 2012 99 117
47. H.M. Chiu, Y.C. Lee, C.H. Tu, C.C. Chen, P.H. Tseng, J.T. Liang, and et al. Association between early stage colon neoplasms and false-negative results from the fecal immunochemical test Clin Gastroenterol Hepatol 11 2013 832-8 e1-2
48. M.C. Wong, J.Y. Ching, V.C. Chan, T.Y. Lam, J.P. Shum, A.K. Luk, and et al. Diagnostic accuracy of a qualitative fecal immunochemical test varies with location of neoplasia but not number of specimens Clin Gastroenterol Hepatol 13 2015 1472 1479
49. T.R. de Wijkerslooth, E.M. Stoop, P.M. Bossuyt, G.A. Meijer, M. van Ballegooijen, A.H. van Roon, and et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia Am J Gastroenterol 107 2012 1570 1578
50. U. Haug, K.M. Kuntz, A.B. Knudsen, S. Hundt, and H. Brenner Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia Br J Cancer 104 2011 1779 1785
51. M.C. Wong, J.Y. Ching, V.C. Chan, T.Y. Lam, A.K. Luk, S.S. Ng, and et al. Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening Gastrointest Endosc 81 2015 596 607
52. C.S. Liao, Y.M. Lin, H.C. Chang, Y.H. Chen, L.W. Chong, C.H. Chen, and et al. Application of quantitative estimates of fecal hemoglobin concentration for risk prediction of colorectal neoplasia World J Gastroenterol 19 2013 8366 8372
53. L.S. Chen, A.M. Yen, S.Y. Chiu, C.S. Liao, and H.H. Chen Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort Lancet Oncol 12 2011 551 558
54. L.S. Chen, A.M. Yen, C.G. Fraser, S.Y. Chiu, J.C. Fann, P.E. Wang, and et al. Impact of faecal haemoglobin concentration on colorectal cancer mortality and all-cause death BMJ Open 3 2013 e003740
55. K.G. Yeoh, K.Y. Ho, H.M. Chiu, F. Zhu, J.Y. Ching, D.C. Wu, and et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects Gut 60 2011 1236 1241
56. MOH clinical practice guidelines: cancer screening 2010 Ministry of Health Singapore 978-981-08-5215-3